ID: ALA4786569

Max Phase: Preclinical

Molecular Formula: C12H15NO

Molecular Weight: 189.26

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  OC1C=CCN(Cc2ccccc2)C1

Standard InChI:  InChI=1S/C12H15NO/c14-12-7-4-8-13(10-12)9-11-5-2-1-3-6-11/h1-7,12,14H,8-10H2

Standard InChI Key:  GLQFCKBSTGMWFY-UHFFFAOYSA-N

Associated Targets(non-human)

Choline trimethylamine-lyase 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 189.26Molecular Weight (Monoisotopic): 189.1154AlogP: 1.42#Rotatable Bonds: 2
Polar Surface Area: 23.47Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.35CX LogP: 1.64CX LogD: 0.64
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.71Np Likeness Score: 0.16

References

1. Bollenbach M,Ortega M,Orman M,Drennan CL,Balskus EP.  (2020)  Discovery of a Cyclic Choline Analog That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria.,  11  (10): [PMID:33062182] [10.1021/acsmedchemlett.0c00005]

Source